FDA-cleared profile

ARTHUR

ROPCA ApS · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.

Clinical role
Robotic ultrasound image acquisition, not autonomous diagnosis
Images and patients
Ultrasound · Hand/Wrist
Key limitation
Keep in mind: Requires professional supervision and compatible cleared ultrasound equipment; provides no diagnostic decisions. If images are inadequate or absent, the clinician can revert to manual scanning or joint palpation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Hand/Wrist Input: Connected cleared ultrasound equipment/transducer supporting B-mode (2D), color Doppler and/or power Doppler. Camera-based hand and joint localization guides probe positioning.
  • Who uses it?Intended users: Trained healthcare professionals operate or supervise the examination; qualified clinicians review and interpret acquired images.
  • What does the software produce?Output: One grayscale image and one Doppler video for each scanned joint are saved on the platform for clinician review and musculoskeletal assessment.
  • What is its most important limitation?Key limitation: Requires professional supervision and compatible cleared ultrasound equipment; provides no diagnostic decisions. If images are inadequate or absent, the clinician can revert to manual scanning or joint palpation.

Clinical takeaway. Clinical role: Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.

Evidence takeaway. Evidence from the reviewed source record: The FDA summary describes performance and usability studies, including an additional US-clinic study, supporting automatic capture of clinically usable joint images. It does not provide study denominators, participant characteristics or detailed confidence intervals.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Supervised automatic ultrasound image acquisition of hand and wrist joints in adults being investigated or monitored for musculoskeletal disease.
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Robotic ultrasound image acquisition, not autonomous diagnosis
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Connected cleared ultrasound equipment/transducer supporting B-mode (2D), color Doppler and/or power Doppler. Camera-based hand and joint localization guides probe positioning.
  • Exact FDA submission
  • Checked 2026-09-06
Output and clinician action
One grayscale image and one Doppler video for each scanned joint are saved on the platform for clinician review and musculoskeletal assessment.
  • Exact FDA submission
  • Checked 2026-09-06
Care setting
Professional healthcare facility; adult patients undergoing investigation or monitoring of musculoskeletal disease.
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Trained healthcare professionals operate or supervise the examination; qualified clinicians review and interpret acquired images.
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
Requires professional supervision and compatible cleared ultrasound equipment; provides no diagnostic decisions. If images are inadequate or absent, the clinician can revert to manual scanning or joint palpation.
  • Exact FDA submission
  • Checked 2026-09-06

The vendor's broad autonomous/no-direct-staff wording is not used to override the exact FDA supervision requirement.

Evidence summary
The FDA summary describes performance and usability studies, including an additional US-clinic study, supporting automatic capture of clinically usable joint images. It does not provide study denominators, participant characteristics or detailed confidence intervals.
  • Exact FDA submission
  • Checked 2026-09-06

Joint-acquisition success is not diagnostic sensitivity for arthritis. No numeric clinical accuracy is inferred from the acquisition acceptance statement.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The FDA summary describes performance and usability studies, including an additional US-clinic study, supporting automatic capture of clinically usable joint images. It does not provide study denominators, participant characteristics or detailed confidence intervals.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Joint-acquisition success is not diagnostic sensitivity for arthritis. No numeric clinical accuracy is inferred from the acquisition acceptance statement.

Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

No exact-release diagnostic sensitivity for musculoskeletal disease is established; the device acquires images for clinician interpretation.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

No exact-release diagnostic specificity for musculoskeletal disease is established.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K260190 acquisition performance and usability studies

  • DesignManufacturer-summarized acquisition performance and usability studies, with an additional US-clinic evaluation
  • PopulationAdult hand/finger/wrist joint ultrasound workflow; participant and joint denominators not provided in the public summary
  • Scopeexact submission
  • Tested versionARTHUR configuration submitted in K260190
  • IndependenceSponsor or vendor study

K260190

Summary supports image acquisition rather than autonomous diagnostic decisions; no numeric arthritis-detection endpoint is reported here.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

Downloaded exact-ID recall packet contained zero records; this limited result does not establish absence of recall or safety information.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Connected cleared ultrasound equipment/transducer supporting B-mode (2D), color Doppler and/or power Doppler. Camera-based hand and joint localization guides probe positioning.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-06 · ARTHUR: K260190 clearance, indications and 510(k) summary

  2. Routing

    Source context, not route validation: Communicates with the ultrasound machine to switch grayscale and Doppler modes during scanning. A touchscreen guides hand placement and gel application under healthcare-professional supervision.

    Scope: Exact FDA submission. Exact scanner/probe model compatibility, PACS interfaces and export formats are not established by this summary.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-06 · ARTHUR: K260190 clearance, indications and 510(k) summary

  3. AI processing

    Source context, not route validation: Physical robotic accessory connected to off-the-shelf cleared ultrasound equipment in a healthcare facility.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-06 · ARTHUR: K260190 clearance, indications and 510(k) summary

  4. Returned objects

    Source context, not route validation: One grayscale image and one Doppler video for each scanned joint are saved on the platform for clinician review and musculoskeletal assessment.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-06 · ARTHUR: K260190 clearance, indications and 510(k) summary

  5. Viewer/worklist/report

    Unresolved route: One grayscale image and one Doppler video for each scanned joint are saved on the platform for clinician review and musculoskeletal assessment.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-06 · ARTHUR: K260190 clearance, indications and 510(k) summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Physical robotic accessory connected to off-the-shelf cleared ultrasound equipment in a healthcare facility.
  • Exact FDA submission
  • Checked 2026-09-06
Integration
Communicates with the ultrasound machine to switch grayscale and Doppler modes during scanning. A touchscreen guides hand placement and gel application under healthcare-professional supervision.
  • Exact FDA submission
  • Checked 2026-09-06

Exact scanner/probe model compatibility, PACS interfaces and export formats are not established by this summary.

Monitoring
The summary describes planned continuation of EU post-market surveillance and collection of performance, safety and usability data by ROPCA.
  • Exact FDA submission
  • Checked 2026-09-06

This is the manufacturer's submitted surveillance description, not an independently audited current service-level commitment.

Supervised robotic scanning

Touchscreen-guided positioning and gel application with camera localization, robotic probe control and grayscale/Doppler acquisition.

exact submission · checked 2026-09-06

Separate analysis workflow

Current vendor workflow places DIANA analysis/report generation after ARTHUR acquisition; these are separate named products.

product family · checked 2026-09-06
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K260190
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Hand/Wrist
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-06-18
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
16Fields reviewed
9Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads

All 20 stored PubMed records were screened as personal-name/biographical ARTHUR matches rather than the ROPCA device. All ten stored trials concern unrelated drug, cancer, pain, endoscopy or lens-solution interventions; none is promoted. Vendor-linked ultrasound papers are separate discovery leads, not these candidates. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-06 - Exact FDA submission

    Reviewed vendor page offers a demo, not a verified robot, ultrasound-system, service or consumable price.

  • Pricing model: Not verified - checked 2026-09-06 - Exact FDA submission

    Purchase/lease options and any separate DIANA license are not established.

  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "ROPCA ARTHUR ultrasound reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-06 - Exact FDA submission

    Mechanical/electrical safety testing and corporate quality claims do not establish current cybersecurity certification, image retention or network security for the installed robot.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-06 - Exact FDA submission

    Supervised use is established, but the exact operator curriculum, competency assessment and retraining schedule are not public in reviewed materials.

6 sources - 3 history items

Source ledger

  1. ARTHUR: K260190 clearance, indications and 510(k) summary

    U.S. Food and Drug Administration - Accessed 2026-09-06

    Scope: purpose, clinicalUse, modality, anatomy, input, output, limitations, deployment, integration, monitoring, evidenceStudies

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. ARTHUR product and ARTHUR-to-DIANA workflow

    ROPCA - Accessed 2026-09-06

    Scope: productFamilyContext, implementationCapabilities

Research history

  1. K260190 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260667

Alturion Series Diagnostic Ultrasound System

Philips Ultrasound, LLC

Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Decision
2026-06-29
FDA-cleared K260844

ACUSON Sequoia Diagnostic Ultrasound System;ACUSON Sequoia Select Diagnostic Ultrasound System;ACUSON Origin Diagnostic Ultrasound System;ACUSON Origin ICE Diagnostic Ultrasound System

Siemens Medical Solutions USA, Inc.

Authorized purpose: ACUSON Sequoia, Select, Origin, and Origin ICE diagnostic ultrasound systems acquire and display the labeled fetal, abdominal, pediatric, neonatal, cephalic, small-part, obstetric, cardiac, transesophageal, intracardiac, vascular, and musculoskeletal examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; transesophageal and intracardiac applications
Decision
2026-06-16
FDA-cleared K260300

WatchMate Software

Anumana, Inc.

Authorized purpose: WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during left-atrial-appendage closure.

Modality
Ultrasound
Anatomy
Heart and left atrial appendage
Decision
2026-06-15
FDA-cleared K261519

Sonio Suspect

Sonio

Authorized purpose: Concurrent physician reading aid for specified abnormal fetal ultrasound findings; patient management must not rely solely on the analysis.

Modality
Ultrasound
Anatomy
Obstetric/Fetal
Decision
2026-06-04

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history